104 related articles for article (PubMed ID: 1559570)
1. Interferon-alpha-induced changes in surface antigens in a hairy-cell leukemia (JOK-1), and a Burkitt's lymphoma cell line (Daudi) during in vitro culture.
Nielsen B; Madsen PS; Jensen AW; Hokland P; Hokland M
Eur J Haematol; 1992 Mar; 48(3):146-51. PubMed ID: 1559570
[TBL] [Abstract][Full Text] [Related]
2. Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study.
Madsen PS; Nielsen B; Jensen AW; Justesen J; Ellegaard J; Hokland P; Hokland M
J Interferon Res; 1992 Oct; 12(5):345-53. PubMed ID: 1431314
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
4. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-IFN on cytokine-induced antigen expression and secretion of TNF, LT and IgM in HCL.
Hassan IB; Lantz M; Sundström C
Leuk Res; 1991; 15(10):903-10. PubMed ID: 1921451
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.
Kumar R; Atlas I
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6599-603. PubMed ID: 1631162
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
9. Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines.
Milner AE; Grand RJ; Gregory CD
Int J Cancer; 1995 May; 61(3):348-54. PubMed ID: 7729947
[TBL] [Abstract][Full Text] [Related]
10. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
11. Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
Maloney MD; Binnington-Boyd B; Lingwood CA
Glycoconj J; 1999 Dec; 16(12):821-8. PubMed ID: 11133022
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action of interferon-alpha 2 in hairy cells and lymphoblastoid cell lines: the significance of type I interferon receptors and RNA synthesis].
Schwabe M; Wagner L; Prischl F; Pinter G; Schwarzmeier JD
Onkologie; 1988 Aug; 11(4):155-8. PubMed ID: 2972979
[TBL] [Abstract][Full Text] [Related]
13. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic changes on hairy cells exposed in vitro to interferons: a quantitative FACS study.
Till KJ; Cawley JC
Br J Haematol; 1989 Jul; 72(3):378-86. PubMed ID: 2504270
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Ii-derived p25 and of P67/69 in hairy leukemic cells.
Yao XR; Humphreys RE
Leuk Res; 1988; 12(10):787-94. PubMed ID: 3264359
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic changes associated with chemically induced differentiation of a hairy cell leukemia cell line.
Hooper WC; Barth RF; Minowada J
Am J Hematol; 1987 Apr; 24(4):401-14. PubMed ID: 3471085
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression.
L'Faqihi FE; Guiraud M; Dastugue N; Brousset P; Le Bouteiller P; Halary F; Bonneville M; Fournié JJ; Champagne E
Hum Immunol; 1999 Oct; 60(10):928-38. PubMed ID: 10566592
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
